Federated Hermes, Inc. Denali Therapeutics Inc. Transaction History

Federated Hermes, Inc.

$43.6 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$20.63 - $30.17 $5.95 Million - $8.7 Million	288,400 Added 27.12%	1,351,900 $27.9 Million
Q1 2023 May 08, 2023	BUY	$21.91 - $32.67 $6.32 Million - $9.43 Million	288,500 Added 37.23%	1,063,500 $24.5 Million
Q4 2022 Feb 13, 2023	BUY	$26.28 - $33.92 $3.11 Million - $4.02 Million	118,407 Added 18.03%	775,000 $21.6 Million
Q3 2022 Nov 14, 2022	SELL	$25.97 - $38.53 $320,365 - $475,306	-12,336 Reduced 1.84%	656,593 $20.2 Million
Q2 2022 Aug 15, 2022	SELL	$20.88 - $35.19 $4.93 Million - $8.32 Million	-236,316 Reduced 26.11%	668,929 $19.7 Million
Q1 2022 May 13, 2022	BUY	$29.0 - $47.27 $4.92 Million - $8.03 Million	169,813 Added 23.09%	905,245 $29.1 Million
Q4 2021 Feb 14, 2022	BUY	$42.59 - $55.02 $16.9 Million - $21.8 Million	396,272 Added 116.84%	735,432 $32.8 Million
Q3 2021 Nov 15, 2021	BUY	$48.48 - $78.23 $9.72 Million - $15.7 Million	200,528 Added 144.65%	339,160 $17.1 Million
Q2 2021 Aug 16, 2021	BUY	$50.3 - $78.44 $436,201 - $680,231	8,672 Added 6.67%	138,632 $10.9 Million
Q1 2021 May 13, 2021	SELL	$53.8 - $81.53 $5.61 Million - $8.5 Million	-104,240 Reduced 44.51%	129,960 $7.42 Million
Q4 2020 Feb 12, 2021	BUY	$36.89 - $93.56 $3.91 Million - $9.92 Million	106,005 Added 82.69%	234,200 $19.6 Million
Q3 2020 Nov 12, 2020	SELL	$23.13 - $38.84 $3.45 Million - $5.8 Million	-149,268 Reduced 53.8%	128,195 $4.59 Million
Q2 2020 Aug 13, 2020	BUY	$16.01 - $28.82 $4.44 Million - $8 Million	277,463 New	277,463 $6.71 Million
Q3 2019 Nov 14, 2019	SELL	$15.32 - $21.92 $1.59 Million - $2.27 Million	-103,755 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$18.5 - $28.14 $15,410 - $23,440	833 Added 0.81%	103,755 $2.15 Million
Q1 2019 May 10, 2019	BUY	$17.99 - $24.65 $1.85 Million - $2.54 Million	102,922 New	102,922 $2.39 Million

Others Institutions Holding DNLI

# of Institutions

227

Shares Held

119M

Call Options Held

60.6K

Put Options Held

48.4K

Baillie Gifford & CO

13.3M
Shares

$287 Million
0.3% of portfolio
Black Rock Inc. New York, NY

13.2M
Shares

$283 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

11.2M
Shares

$240 Million
0.01% of portfolio
Wellington Management Group LLP Boston, MA

10.7M
Shares

$231 Million
0.06% of portfolio
Capital Research Global Investors Los Angeles, CA

7.91M
Shares

$170 Million
0.05% of portfolio

View Full List

About Denali Therapeutics Inc.

Ticker DNLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 134,174,000
Market Cap $2.88B
Description
Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...

More about DNLI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.

Account